0.2385
price down icon6.65%   -0.017
 
loading

Finanzdaten der Genprex Inc-Aktie (GNPX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Research and Development
11.81%
3.2744
3.713 4.6165 3.9769 5.3101
Costs And Expenses
0.17%
5.9967
5.9867 7.7863 8.0357 9.2712
Operating Income/Loss
0.17%
-5.9967
-5.9867 -7.7863 -8.0357 -9.2712
Income/Loss From Continuing Operations Before Tax
0.17%
-5.9967
-5.9867 -7.7863 -7.9802 -9.2028
Income/Loss From Continuing Operations After Tax
0.67%
-5.9689
-5.9293 -7.7482 -7.9802 -9.2028
Net Income/Loss
0.67%
-5.9689
-5.9293 -7.7482 -7.9802 -9.2028
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
103.13%
1.6182
-51.75 57.81 51.98 49.47
Basic Earnings Per Share
83.30%
-3.69
-22.09 -0.13 -0.15 -0.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$19.50
price down icon 0.36%
$70.20
price down icon 0.28%
$32.45
price up icon 0.47%
$23.68
price down icon 0.15%
$97.89
price down icon 0.37%
biotechnology ONC
$231.69
price up icon 1.29%
Kapitalisierung:     |  Volumen (24h):